rs2277503

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_001355436.2(SPTB):​c.177C>T​(p.Thr59Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0483 in 1,614,128 control chromosomes in the GnomAD database, including 2,448 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.046 ( 231 hom., cov: 32)
Exomes 𝑓: 0.048 ( 2217 hom. )

Consequence

SPTB
NM_001355436.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 3.46

Publications

13 publications found
Variant links:
Genes affected
SPTB (HGNC:11274): (spectrin beta, erythrocytic) This locus encodes a member of the spectrin gene family. Spectrin proteins, along with ankyrin, play a role in cell membrane organization and stability. The protein encoded by this locus functions in stability of erythrocyte membranes, and mutations in this gene have been associated with spherocytosis type 2, hereditary elliptocytosis, and neonatal hemolytic anemia. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]
SPTB Gene-Disease associations (from GenCC):
  • hereditary spherocytosis type 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • elliptocytosis 3
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • hereditary elliptocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary spherocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.35).
BP6
Variant 14-64805062-G-A is Benign according to our data. Variant chr14-64805062-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 257099.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=3.46 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.171 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPTBNM_001355436.2 linkc.177C>T p.Thr59Thr synonymous_variant Exon 3 of 36 ENST00000644917.1 NP_001342365.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPTBENST00000644917.1 linkc.177C>T p.Thr59Thr synonymous_variant Exon 3 of 36 NM_001355436.2 ENSP00000495909.1 P11277-2
SPTBENST00000389722.7 linkc.177C>T p.Thr59Thr synonymous_variant Exon 2 of 35 2 ENSP00000374372.3 P11277-2
SPTBENST00000389720.4 linkc.177C>T p.Thr59Thr synonymous_variant Exon 3 of 32 5 ENSP00000374370.4 P11277-1

Frequencies

GnomAD3 genomes
AF:
0.0465
AC:
7069
AN:
152120
Hom.:
230
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0372
Gnomad AMI
AF:
0.0164
Gnomad AMR
AF:
0.0341
Gnomad ASJ
AF:
0.0446
Gnomad EAS
AF:
0.182
Gnomad SAS
AF:
0.0589
Gnomad FIN
AF:
0.0327
Gnomad MID
AF:
0.114
Gnomad NFE
AF:
0.0459
Gnomad OTH
AF:
0.0502
GnomAD2 exomes
AF:
0.0528
AC:
13275
AN:
251452
AF XY:
0.0534
show subpopulations
Gnomad AFR exome
AF:
0.0378
Gnomad AMR exome
AF:
0.0223
Gnomad ASJ exome
AF:
0.0439
Gnomad EAS exome
AF:
0.173
Gnomad FIN exome
AF:
0.0319
Gnomad NFE exome
AF:
0.0488
Gnomad OTH exome
AF:
0.0463
GnomAD4 exome
AF:
0.0485
AC:
70889
AN:
1461890
Hom.:
2217
Cov.:
34
AF XY:
0.0490
AC XY:
35648
AN XY:
727244
show subpopulations
African (AFR)
AF:
0.0375
AC:
1257
AN:
33480
American (AMR)
AF:
0.0242
AC:
1082
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0474
AC:
1239
AN:
26136
East Asian (EAS)
AF:
0.157
AC:
6217
AN:
39700
South Asian (SAS)
AF:
0.0559
AC:
4823
AN:
86258
European-Finnish (FIN)
AF:
0.0324
AC:
1733
AN:
53420
Middle Eastern (MID)
AF:
0.0534
AC:
308
AN:
5768
European-Non Finnish (NFE)
AF:
0.0459
AC:
51034
AN:
1112008
Other (OTH)
AF:
0.0529
AC:
3196
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
3913
7825
11738
15650
19563
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1954
3908
5862
7816
9770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0465
AC:
7075
AN:
152238
Hom.:
231
Cov.:
32
AF XY:
0.0464
AC XY:
3457
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.0375
AC:
1559
AN:
41554
American (AMR)
AF:
0.0340
AC:
520
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0446
AC:
155
AN:
3472
East Asian (EAS)
AF:
0.180
AC:
933
AN:
5172
South Asian (SAS)
AF:
0.0587
AC:
282
AN:
4802
European-Finnish (FIN)
AF:
0.0327
AC:
347
AN:
10610
Middle Eastern (MID)
AF:
0.116
AC:
34
AN:
294
European-Non Finnish (NFE)
AF:
0.0459
AC:
3125
AN:
68014
Other (OTH)
AF:
0.0497
AC:
105
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
341
682
1022
1363
1704
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
90
180
270
360
450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0484
Hom.:
835
Bravo
AF:
0.0471
Asia WGS
AF:
0.0900
AC:
314
AN:
3478
EpiCase
AF:
0.0483
EpiControl
AF:
0.0500

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Nov 26, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Elliptocytosis Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Spherocytosis, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.35
CADD
Benign
9.2
DANN
Benign
0.69
PhyloP100
3.5
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2277503; hg19: chr14-65271780; COSMIC: COSV67632090; API